source
- NewLimit secures $435M funding, valuation tops $3B, aims for human trials in 2027NewLimit, a Bay Area anti-aging biotech, announced a financing round that raised $435 million, valuing the company at more than $3 billion. The round is among the largest private biotech financing…
- Eli Lilly gives 340B hospitals a week to share data or lose drug discountsEli Lilly has told hospitals and medical groups that participate in the 340B drug discount program that they must submit claims data for all Lilly medications by the coming Monday, or they will be…